LOGIN  |  REGISTER
Chimerix
Amneal Pharmaceuticals

Universal Health Services To Present At The 44th Annual Goldman Sachs Global Healthcare Conference

May 31, 2023 | Last Trade: US$165.90 0.99 0.60

KING OF PRUSSIA, Pa., May 31, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will participate in a fireside chat at the 44th Annual Goldman Sachs Global Healthcare Conference on Monday, June 12, 2023, at 4:40pm (PT)/7:40pm (ET).

A live audio webcast of the presentation will be available on the Company's website (www.uhs.com).  For those unable to listen to the live webcast, a replay of the presentation will be available on the Company's website for 90 days following the conference.

Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.

Stock Quote

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB